Europe Custom Antibody Services Market
No. of Pages: 234 | Report Code: BMIRE00032162 | Category: Life Sciences
No. of Pages: 234 | Report Code: BMIRE00032162 | Category: Life Sciences
The Europe custom antibody services market size is expected to reach US$ 395.31 million by 2031 from US$ 194.22 million in 2023. The market is estimated to record a CAGR of 9.3% from 2023 to 2031.
The custom antibody services market in Europe is experiencing steady growth, driven by increasing demand for personalized medicine, advanced research in oncology and neurology, and the expansion of biotech and pharmaceutical sectors. European countries such as Germany, the UK, and France are leading contributors due to strong research infrastructure and funding support. The rising focus on targeted therapeutics and the growing adoption of recombinant antibodies are also fueling market expansion. Additionally, collaborations between academic institutions and contract research organizations (CROs) are enhancing innovation. Regulatory support and technological advancements further strengthen Europe's position in the global custom antibody services market.
Key segments that contributed to the derivation of the Europe custom antibody services market analysis are product type, service type, application, disease indication, source, and end user.
Governments of emerging countries are launching several research and development initiatives focusing on genomics and proteomic methods. Europe is making significant strides in genomics research through various initiatives and funding programs. The 1+ Million Genomes (1+MG) initiative, launched in 2018, aims to securely make genomic and health data accessible across Europe, backed by a €20 million grant for the Genome of Europe project. The Horizon Europe program, along with its predecessor Horizon 2020, has funded numerous genomics projects, including QUANTOMICS, which focuses on livestock genomics. Also, the Marie Skłodowska-Curie Actions (MSCA) offers €6.6 billion in fellowships to support interdisciplinary research, including in genomics. Additionally, EU4Health, with a budget of €5.1 billion, supports healthcare initiatives related to genomics. ELIXIR also plays a key role by facilitating the sharing and storage of genomic data across European laboratories. Therefore, the rise in research and development initiatives by governments of various developing economies is expected to create lucrative opportunities for the growth of the custom antibody services market during the forecast period.
Based on country, the Europe custom antibody services market comprises the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany held the largest share in 2023.
The custom antibody services market in Germany is anticipated to grow significantly during the forecast period owing to the increasing prevalence of chronic diseases. Cancer is one of the leading causes of morbidity and mortality in the country. According to the World Health Organization (WHO), Germany recorded 628,519 new cancer cases and 252,065 deaths in 2020. The rising number of cancer cases in Germany propels the demand for better treatment options. Custom antibodies can help target specific tumor markers, improving the efficacy and reducing side effects of cancer treatment. In September 2023, AMSBIO supplied a custom monoclonal antibody to researchers at the Technical University Dortmund, Germany, to unravel the role of EDI3 (a glycerophosphodiesterase enzyme involved in choline metabolism) in breast cancer development, its regulation by HER2 signaling, and its potential as a therapeutic target. By using the custom monoclonal antibody, the researchers have demonstrated that inhibiting EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumor growth.
Custom antibodies have applications in stem cell research, immunology, and other novel fields of healthcare. The presence of various market players offering custom antibody services also favors the market growth in Europe. BioGenes GmbH is a company based in Germany that provides a wide range of custom antibodies such as COVID-19-specific antibodies, monoclonal antibodies, polyclonal antibodies, anti-idiotypic antibodies (both monoclonal and polyclonal), and additional services. The company is also actively involved in product innovation and development, and it has generated monoclonal and polyclonal antibodies targeting proteins, small molecules, peptides, modified peptides, drug substances, and antibodies (anti-idiotypic antibodies). It offers several services for antibody modification. Thus, active research activities and the presence of market players in the country are likely to support the growth of the market in Germany.
Some of the key players operating in the market include Thermo Fisher Scientific Inc; Sino Biological Inc.; GenScript Biotech Corporation; Biochain Incorporated; R&D Systems, Inc; Kaneka Eurogentec S.A.; Fortis Life Sciences; Precision Antibody (A&G Pharmaceutical, Inc.; Biocytogen Pharmaceuticals Beijing Co Ltd; Abgenex; Creative Biolabs Inc; Agilent Technologies Inc; Bioklone; and Scantibodies Laboratory, Inc. among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
The following methodology has been followed for the collection and analysis of data presented in this report:
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.
The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:
Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
The Europe Custom Antibody Services Market is valued at US$ 194.22 Million in 2023, it is projected to reach US$ 395.31 Million by 2031.
As per our report Europe Custom Antibody Services Market, the market size is valued at US$ 194.22 Million in 2023, projecting it to reach US$ 395.31 Million by 2031. This translates to a CAGR of approximately 9.3% during the forecast period.
The Europe Custom Antibody Services Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Custom Antibody Services Market report:
The Europe Custom Antibody Services Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Custom Antibody Services Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Custom Antibody Services Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Custom Antibody Services Market
